Some breast cancers may spontaneously disappear

NEW YORK (Reuters Health) - The results of a mammographic screening study suggest that some invasive breast cancers may spontaneously regress over time.

These findings “provide new insight on what is arguably the major harm associated with mammographic screening, namely, the detection and treatment of cancers that would otherwise regress,” Dr. H. Gilbert Welch, from the Department of Veteran Affairs Medical Center, White River Junction, Vermont, and colleagues state.

The study, which is published in the Archives of Internal Medicine, involved 119,472 women, from 50 to 64 years of age, who underwent three rounds of mammography screening from 1996 to 2001 as part of the Norwegian Breast Cancer Screening Program. The cancer rates in this group were compared with those in 109,784 control women who would have been screened had the program been in place in 1992.

Women in the control group were invited to undergo a one-time screen at the conclusion of their observation period, the authors explain.

As anticipated, the 4-year cumulative incidence of invasive breast cancer in the screened group was higher than in the control group before screening: 1268 vs. 810 cases per 100,000 population.

However, even after the one-time screen in the control group, the 6-year cumulative incidence of breast cancer in the screened group was still higher: 1909 vs. 1564 cases per 100,000 population.

“Because the cumulative incidence among controls never reached that of the screened group, it appears that some breast cancers detected by repeated mammographic screening would not persist to be detectable by a single mammogram at the end of 6 years,” Welch and colleagues conclude.

“If the ’spontaneous remission’ hypothesis is credible, it should cause a major reevaluation in the approach to breast cancer research and treatment,” Dr. Robert M. Kaplan, from University of California, Los Angeles, and Dr. Franz Porzsolt, from the University of Ulm, Germany, write in a related editorial. “Certainly it is worthy of further evaluation. But, finding better data to assess the hypothesis will be difficult.”

SOURCE: Archives of Internal Medicine for November 24, 2008.


Related Posts:

By Michael Kahn LONDON (Reuters) - Researchers who tracked breast cancer rates in Norwegian women proposed the controversial notion on Monday that some tumors found with mammograms might otherwise naturally disappear on their own if left undetected. But leading cancer experts expressed doubt about the findings and urged women to continue to get regular mammograms, saying this

Full Post: Some breast cancers may naturally regress: study

By Julie Steenhuysen CHICAGO (Reuters) - A screening schedule that alternates between a breast MRI and a mammogram every six months may do a better job of spotting early cancers in high-risk women than an annual exam, U.S. researchers said on Saturday. Women who are at high risk for breast cancer currently get a yearly mammogram and

Full Post: Rotating breast cancer tests helps high-risk women

CHICAGO (Reuters) - A study of nearly 40,000 women has found no overall link between caffeine and breast cancer, though some women who have benign breast lumps might be at a higher risk, researcher said on Monday. A few earlier studies had suggested caffeine could play a role in breast cancer among those who consume what

Full Post: No overall caffeine-breast cancer link: study

LONDON (Reuters) - A national screening program in Finland has detected about 40 percent of colon cancers early, showing that such tests can make a difference, Finnish researchers reported on Friday. Researchers studied 106,000 men and women aged between 60 and 64 across Finland to examine the effectiveness of a colon cancer screening program started in

Full Post: Study backs Finland’s colon cancer screening

LONDON (Reuters) - The first baby girl in Britain to have been screened before conception for a genetic form of breast cancer has been born, doctors said on Friday. While a first in Britain, the strategy has been used elsewhere across the world to screen for the cancer-related BRCA1 gene variant, and the technique has also

Full Post: UK’s first breast cancer gene screen baby born

Site Navigation

Most Read